BAM
AMRX icon

Blueshift Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Blueshift Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,739
Closed -$122K – 987
2021
Q2 		$122K Sell
23,739
-15,933
-40% -$90.6K 0.01% 868
2021
Q1 		$267K Buy
+39,672
New +$220K 0.03% 678
2020
Q1 		– Sell
-66,564
Closed -$321K – 198
2019
Q4 		$321K Buy
66,564
+17,294
+35% +$60.1K 0.04% 586
2019
Q3 		$143K Buy
+49,270
New +$172K 0.02% 659

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blueshift Asset Management's AMRX Position: Q3 2021 in Review

Blueshift Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2021, closing a stake of 23,739 shares — an estimated $122K sold.

Blueshift Asset Management first reported a position in AMRX in Q3 2019 and held it in 4 quarters. The position peaked at $321K in Q4 2019. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2021.

  • Blueshift Asset Management reported no remaining Amneal Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 23,739 Amneal Pharmaceuticals shares in Q3 2021, an estimated $122K.
  • Blueshift Asset Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Blueshift Asset Management's Amneal Pharmaceuticals position peaked at $321K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2021.

Based on Blueshift Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.